Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.55 |
| ▸ | OTC | P00480 | 1/20 | 0.53 |
| ▸ | ARG2 | P78540 | 4/20 | 0.50 |
| ▸ | ARG1 | P05089 | 3/20 | 0.50 |
| ▸ | DDAH1 | O94760 | 3/20 | 0.50 |
| ▸ | NOS2 | P35228 | 5/20 | 0.49 |
| ▸ | NOS1 | P29475 | 3/20 | 0.49 |
| ▸ | NOS3 | P29474 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | APEX1 | P27695 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8871251 | 1.00 | GSR (0.55) | GSROTCARG2ARG1DDAH1 | |
| SCHEMBL5279090 | 1.00 | GSR (0.55) | GSROTCARG2ARG1DDAH1 | |
| SCHEMBL9069162 | 1.00 | GSR (0.55) | GSROTCARG2ARG1DDAH1 | |
| SCHEMBL27798566 | 0.98 | GSR (0.53) | GSROTCARG2ARG1DDAH1 | |
| Urea SCHEMBL20898440 | 0.98 | GSR (0.53) | GSROTCARG2ARG1DDAH1 | |
| SCHEMBL21415550 | 0.98 | GSR (0.53) | GSROTCARG2ARG1DDAH1 | |
| L-Citrulline SCHEMBL17164652 | 0.98 | OTC (0.56) | GSROTCARG2ARG1DDAH1 | |
| Sulfuric Acid SCHEMBL18284893 | 0.94 | GSR (0.50) | GSROTCARG2ARG1DDAH1 | |
| L-Citrulline SCHEMBL4542892 | 0.94 | OTC (0.59) | GSROTCARG2ARG1DDAH1 | |
| L-Citrulline SCHEMBL22426116 | 0.94 | OTC (0.59) | GSROTCARG2ARG1DDAH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7858 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748847-A1 | PEPTIDE COMPLEX HAVING VEGFR -2 AGONIST ACTIVITY | Peptidream Inc (JP) | 2026-05-27 | — | — | EP | claimed |
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| CN-122011091-A | Polypeptide compound, preparation method, pharmaceutical composition and application thereof | 中山莱博瑞辰生物医药有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260098061-A1 | EPHA2-BINDING PENDING PEPTIDE AND COMPOSITION COMPRISING SAME | PEPTIDREAM INC (JP) | 2026-04-09 | — | — | US | claimed |
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MARVELBIOME INC (US) | 2026-04-02 | — | — | US | claimed |
| US-20260063601-A1 | PLASMA METABOLOME AS A PREDICTOR OF BIOLOGICAL AGING | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY (US) | 2026-03-05 | — | — | US | claimed |
| EP-4683674-A1 | COMPOSITIONS AND METHODS FOR DELIVERING ANTIBODY OLIGONUCLEOTIDE CONJUGATES FOR EXON SKIPPING | Yale University (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4655007-A1 | ANTIBODY OLIGONUCLEOTIDE CONJUGATES | Yale University (US) | 2025-12-03 | — | — | EP | claimed |
| US-20250361273-A1 | METHODS AND COMPOSITIONS | FLAGSHIP PIONEERING INNOVATIONS VII, LLC | 2025-11-27 | — | — | US | claimed |
| WO-2025245483-A1 | METHODS AND COMPOSITIONS | FLAGSHIP PIONEERING INNOVATIONS VII, LLC (US) | 2025-11-27 | — | — | WO | claimed |
| US-5770692-A | METHOD OF INTRODUCING UREIDO GROUPS INTO PEPTIDES WHILE PRESERVING STEREOCHEMISTRY | PEPTISYNTHA (BE) | 1998-06-23 | — | — | US | claimed |
| EP-0562659-B1 | Process to synthetise peptides and new intermediates thereof | SOLVAY (BE) | 1997-12-17 | — | — | EP | claimed |
| WO-1997011958-A1 | PROTEIN SIGNATURE ANALYSIS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1997-04-03 | — | — | WO | claimed |
| EP-0517778-B1 | VASOACTIVE VASOTOCIN DERIVATIVES | FERRING AB (SE) | 1996-05-08 | — | — | EP | claimed |
| US-5449688-A | Nitric oxide synthase inhibitor or scavenger | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-09-12 | — | — | US | claimed |
| EP-0585412-A1 | INCREASING BLOOD-BRAIN BARRIER PERMEABILITY WITH PERMEABILIZER PEPTIDES | ALKERMES, INC. (US) | 1994-03-09 | — | — | EP | claimed |
| EP-0562659-A1 | Process to synthetise peptides and new intermediates thereof | SOLVAY (Société Anonyme) (BE) | 1993-09-29 | — | — | EP | claimed |
| EP-0517778-A1 | VASOACTIVE VASOTOCIN DERIVATIVES. | FERRING AB (SE) | 1992-12-16 | — | — | EP | claimed |
| WO-1992018529-A1 | INCREASING BLOOD-BRAIN BARRIER PERMEABILITY WITH PERMEABILIZER PEPTIDES | ALKERMES, INC. (US) | 1992-10-29 | — | — | WO | claimed |
| WO-1991013092-A1 | VASOACTIVE VASOTOCIN DERIVATIVES | FERRING AB (SE) | 1991-09-05 | — | — | WO | claimed |